| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $2.4M | +48.6% | +101.6% |
| SG&A Expense | $5.2M | +182.7% | +210.9% |
| Operating Income | -$7.5M | -120.2% | -165.7% |
| Pre-tax Income | -$7.5M | -123.3% | -165.4% |
| Income Tax | $0 | — | — |
| Net Income | -$7.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.5M | -12.9% | +45.0% |
| Current Assets | $7.9M | -12.1% | +47.4% |
| Total Assets | $7.9M | -11.8% | +47.7% |
| Current Liabilities | $1.5M | -24.3% | +18.3% |
| Total Liabilities | $1.5M | -24.3% | -36.5% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.4M | -146.6% | — |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $4.8M | +131.5% | — |
| Free Cash Flow | -$6.4M | -146.6% | — |
| -165.4% |
| EPS (Basic) | -$1.38 | -29.0% | +44.1% |
| $6.4M |
| -8.3% |
| +112.8% |